GeoVax Highlights Dual Protective Potential of GEO-CM04S1 Following Presentation at the AAI Annual Meeting 2025 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
GeoVax Highlights Dual Protective Potential of GEO-CM04S1 Following Presentation at the AAI Annual Meeting 2025 GEO-CM04S1 Demonstrates Robust COVID-19 and Mpox Immunogenicity in Immunocompromised Patients and Healthy Adults
GeoVax Expands Gedeptin(R) Patent Portfolio Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
GeoVax Expands Gedeptin(R) Patent Portfolio Allowed Patent Claims Cover the Synergistic Combination of Gedeptin® Therapy with Radiation As a Targeted Approach for Solid Tumors
GeoVax Presents Gedeptin(R) Clinical Data at the American Association for Cancer Research Annual Meeting Advancing Gene-Directed Prodrug Therapy: Data Presented at AACR Supports Gedeptin’s Potential in Solid Tumors
GeoVax Appoints Dr. Senthil Ranganathan as Vice President, Technical Development and CMC Operations Recognized Biologics Executive to Oversee Critical Expansion of U.S.-Based Development Capabilities
GeoVax Reports First Quarter 2025 Financial Results and Provides Business Update Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
GeoVax Reports First Quarter 2025 Financial Results and Provides Business Update COVID-19 vaccine program progressing with additional data evaluating GEO-CM04S1 as booster to mRNA vaccines in healthy adults expected in second quarter of 2025
GeoVax Presents Gedeptin(R) Clinical Data at the American Association for Cancer Research Annual Meeting Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
GeoVax Responds to Detection of Clade I Mpox in North Carolina Wastewater Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
GeoVax Highlights Strong Clinical Results Following Presentation of Multi-Antigen COVID-19 Vaccine at the 25th Annual World Vaccine Congress Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
GeoVax to Report First Quarter 2025 Financial Results and Provide Corporate Update on May 1, 2025 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
GeoVax Appoints Dr. Senthil Ranganathan as Vice President, Technical Development and CMC Operations Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
GeoVax Highlights New Study Demonstrating the Strength of Multi-Antigen COVID-19 Vaccine Candidates Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
GeoVax Highlights New Study Demonstrating the Strength of Multi-Antigen COVID-19 Vaccine Candidates Peer-Reviewed Data Reinforces GeoVax’s Multi-Antigen Strategy With GEO-CM02 and Supports Advancement of GEO-CM04S1 Clinical Programs
GeoVax Provides Update on BARDA Project NextGen and Outlines 2025 Business Momentum Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Top stock movements in today's session. Here are the top movers in Tuesday's session, showcasing the stocks with significant price changes.
Tuesday's session: top gainers and losers Curious about what's happening in today's session? Check out the latest stock movements and price changes.
GeoVax to Present at the Emerging Growth Conference on April 16, 2025 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
